香蕉久久久 I 国产777 I 中文人妻av大区中文不卡 I 久久综合伊人77777蜜臀 I 婷婷视频导航 I 天天综合永久 I 国产性生交xxxxx免费 I 中文字幕人妻无码视频 I 99精彩视频在线观看 I 久久久久久久久久成人 I 久久精品免视看国产成人2021 I 国产精品精 I 日本又色又爽又黄又高潮 I 国产精选在线播放 I 奇米色7777 I 特级a做爰全过程片 I 激情五月综合五月 I 久久久久久激情 I 在线香蕉视频 I 中文字幕有码av I 色成人 I 日本人zzzwww色视频看看 I 被窝福利片久久福利片 I 色欧美乱欧美乱妇15图片 I 97中文字幕第三 I 成人影院yy111111 I 少妇饥渴xxhd麻豆xxhd骆驼 I 91麻豆精品国产91久久久无需广告 I 国产色在线视频 I 亚洲黄色精品视频 I 免费毛片18女人毛片大全在线看 I 91精品国产日韩一区二区三区 I 亚洲美女视频网

一.產品名稱：

通用名稱：甲狀旁腺激素1-34 ELISA試劑盒

英文名稱：PTH 1-34 ELISA Kit

二.PTH 1-34 ELISA Kit介紹：

Teriparatide (rhPTH 1-34) is a recombinant human parathyroid hormone derivative consisting of the first 34 amino acids of the hormone. Teriparatide was approved as a drug by the FDA in 2002 and is sold by Eli Lilly & Co. under the brand name Forteo. Teriparatide is indicated for use in patients with osteoporosis. It is currently administered by injection and has an anabolic effect on bone, binding to the PTH/PTHrp Type 1 receptor with the same affinity as the intact molecule, PTH (1-84). This receptor activation results in a series of events leading to the formation of new trabecular and cortical bone. Research is continuing at pharmaceutical and biotech companies to pursue similar drugs and alternate delivery pathways.
Immunogenicity for this drug, defined as the presence of antibodies to human PTH (1-34), was detected in 2.8% of women receiving teriparatide during the clinical trials of Forteo. The detection of these
circulating antibodies may be of clinical relevance for the proper assessment of patients.

如需了解更多產品資料，請北京科瑞美公司。